PD-1-IN-20

• UNSPSC Description:

  PD-1-IN-20 is the less active enantiomer of PD-1-IN-1. PD-1-IN-1 is an inhibitor of programmed cell dealth-1 (PD-1) extracted from patent WO 2015033299 A1, compound example 4[1].

• Target Antigen:

  PD-1/PD-L1

• Type:

  Reference compound

• Related Pathways:

  Immunology/Inflammation

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/pd-1-in-20.html

• Solubility:

  10 mM in DMSO

• Smiles:

  N[C@H](CO)C1=NOC([C@@H](NC(N[C@H](C(O)=O)[C@H](C)O)=O)CC(N)=O)=N1

• Molecular Weight:

  360.32

• References & Citations:

  [1]Pottayil Govindan Nair Sasikumar, et al. Dérivés 1,2,4-oxadiazole utilisés comme immunomodulateurs. WO2015033299A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported